Physician
Gastroenterology
Dr. Huy N. Trinh, MD
|
|
Give Review
Huy N. Trinh, MD practices Gastroenterology. He went to Northwestern University Feinberg School of Medicine. Northwestern University Feinberg School of Medicine has a rank of 19 in research and a 29 in primary care He over the years received 1 awards: "Fellow (AGAF)". Doctor Huy N. Trinh, MD is a published MD as well. He has 51 publications published. The latest was: Rates of Treatment Eligibility in Follow-Up of Patients with Chronic Hepatitis B (CHB) Across Various Clinical Settings Who Were Initially Ineligible at Presentation. He is registered with Medicare and accepts Medicare payments.
Publications
- Treatment Outcomes With First-line Therapies With Entecavir and Tenofovir in Treatment-Naive Chronic Hepatitis B Patients in a Routine Clinical Practice.
- Rates of Treatment Eligibility in Follow-Up of Patients with Chronic Hepatitis B (CHB) Across Various Clinical Settings Who Were Initially Ineligible at Presentation.
- Intimate partner violence education for medical students in the USA, Vietnam and China.
- Association of baseline vitamin D levels with clinical parameters and treatment outcomes in chronic hepatitis B.
- Entecavir safety and effectiveness in a national cohort of treatment-naïve chronic hepatitis B patients in the US - the ENUMERATE study.
- Viral suppression and cirrhosis regression with tenofovir disoproxil fumarate in Asians with chronic hepatitis B.
- Tenofovir-based alternate therapies for chronic hepatitis B patients with partial virological response to entecavir.
- Low treatment rates in patients meeting guideline criteria in diverse practice settings.
- Entecavir Is Safe and Effective in Patients Previously Treated with Adefovir, including Those with Adefovir-Resistance.
- Letter: treatment of HBeAg+ chronic hepatitis B - is tenofovir truly superior to entecavir? Authors' reply.
- Commentary: tenofovir is superior to entecavir in HBeAg-positive chronic hepatitis B patients - authors' reply.
- Tenofovir is superior to entecavir for achieving complete viral suppression in HBeAg-positive chronic hepatitis B patients with high HBV DNA.
- Mutations in HBV DNA Polymerase Associated with Nucleos(t)ide resistance are Rare in Treatment-naïve Patients.
- Similar Response to Entecavir 0.5 and 1.0 Mg in Treatment-Naïve Chronic Hepatitis B Patients: A Case-Control Study.
- Less-established risk factors are common in asian americans with hepatitis C virus: a case-controlled study.
- Prevalence, Risk Factors, and Disease Knowledge of Chronic Hepatitis B Infection in Vietnamese Americans in California.
- High proportion of hepatitis C virus in community Asian American patients with non-liver-related complaints.
- Precore and basal core promoter mutations in Asian American patients with hepatitis B e antigen-positive chronic hepatitis B.
- Treatment Eligibility of Patients with Chronic Hepatitis B Initially Ineligible for Therapy.
- Low Incidence of Hepatitis B e Antigen Seroconversion in Patients Treated with Oral Nucleos(t)ides in Routine Practice.
- Low hepatitis B envelope antigen seroconversion rate in chronic hepatitis B patients on long-term entecavir 0.5 mg daily in routine clinical practice.
- Tenofovir monotherapy and tenofovir plus entecavir combination as rescue therapy for entecavir partial responders.
- Response to higher dose of entecavir 1.0 mg daily in patients with partial response to entecavir 0.5 mg daily.
- Liver disease in Viet Nam: screening, surveillance, management and education: a 5-year plan and call to action.
- The efficacy of entecavir therapy in chronic hepatitis B patients with suboptimal response to adevofir.
- High Rate of Complete Viral Suppression With Combination Therapy in Patients With Chronic Hepatitis B and Prior Treatment Failure.
- Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection.
- Medication Nonadherence with Long-Term Management of Patients with Hepatitis B e antigen-Negative Chronic Hepatitis B.
- Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B.
- Randomized controlled trial of pegylated interferon-alfa 2a and ribavirin in treatment-naive chronic hepatitis C genotype 6.
- Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with chronic-hepatitis B virus infection.
- Response to pegylated interferon and ribavirin in Asian American patients with chronic hepatitis C genotypes 1 vs 2/3 vs 6.
- Similar treatment response to peginterferon and ribavirin in Asian and Caucasian patients with chronic hepatitis C.
- Risk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans.
- Prevalence of hepatitis B virus DNA polymerase mutations in treatment-naïve patients with chronic hepatitis B.
- Adherence to screening for hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting.
- Histological disease in Asian-Americans with chronic hepatitis B, high hepatitis B virus DNA, and normal alanine aminotransferase levels.
- Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil.
- Prevalence of hepatitis B virus genotype B in Vietnamese patients with chronic hepatitis B.
- Clinical course of hepatitis B virus infection during pregnancy.
- Prevalence of colorectal neoplasms in Asian Americans.
- Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.
- Low proportion of Barrett's esophagus in Asian Americans.
- Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels.
- Higher rate of sustained virologic response in chronic hepatitis C genotype 6 treated with 48 weeks versus 24 weeks of peginterferon plus ribavirin.
- Safety and antiviral activity of emtricitabine (FTC) for the treatment of chronic hepatitis B infection: a two-year study.
- Unsedated ultrathin EGD is well accepted when compared with conventional sedated EGD: a multicenter randomized trial.
- Dose range study of pharmacokinetics, safety, and preliminary antiviral activity of emtricitabine in adults with hepatitis B virus infection.
- Dexamethasone increases the expression of membrane macrophage colony stimulating factor from retrovirally transduced tumor cells expressing macrophage colony stimulati...
- Long-term follow-up and suboptimal treatment rates of treatment-eligible chronic hepatitis B patients in diverse practice settings: a gap in linkage to care.
Schools
Northwestern University Medical School
Va WadsworthUniversity Of California Medical Center
University Of California Medical Center
UC Irvine
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- Hemorrhoidectomy or Excision of Anal Tags
- Manometry
Doctors Specialties
- Gastroenterology
Accepted Insurances
Awards
- Fellow (AGAF)
Education
-
University of California Irvine -
VA Greater Los Angeles Healthcare System -
Northwestern University Feinberg School of Medicine
Drug Facts
| NPI NUMBER | 1326041658 | |
| NPPES Provider LastName | TRINH | |
| NPPES Provider FirstName | HUY | |
| NPPES Provider ZIPCode | 951161622 | |
| NPPES Provider State | CA | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 1763.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1326041658 |
| Last Name Of The Provider | TRINH |
| First Name Of The Provider | HUY |
| View All |
Similar Doctors
|
|
Dr. Terry Lin, DO
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alfred L. Hurwitz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David W. Chui, MD |
|
|
Dr. Andy S. Yu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nimeesh K. Shah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hashem M. Farr, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ahmad Kamal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raymond H. Tu, MD |
|
Dr. Khanh K. Nguyen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bailey V. Vittal, MD
This Doctor is OpenDoctor Recommended.
|